James F. Fries

Boers M, Brooks P, Fries JF, et al. Tools for benefit-risk assessment: Scholarly review revealed lack of evidence for validity and applicability. J Clin Epidemiology, In Press.
Bruce B, Fries JF, Hubert H. Regular Vigorous Physical Activity and Disability Development in Healthy Overweight and Normal-Weight Seniors: A 13-Year Study. American Journal of Public Health 2008 98(7): 1294-1299.
Chakravarty EF, Hubert HB, Lingala VB, Zatarain E, Fries JF. Long Distance Running and Knee Osteoarthritis: A Prospective Study. Am J Prev Med. 2008 Aug;35(2):133-8.
Chakravarty EF, Hubeert HB, Lingala VB, Fries JF. Reduced Disability and Mortality Among Aging Runners. Arch Intern Med 2008; 168(15): 1638-1646.
Fries JF, Bruce B, Rose M. Comparison of the health assessment questionnaire disability index and the short form 36 physical functioning subscale using Rasch analysis: Comment on the article by Taylor and McPherson. Arthritis Rheum. 2008 Apr 15;59(4)-598-9.
Rose M, Bjorner J.B., Becker J, Fries J.F. Ware J.E. Evaluation of a preliminary physical function item bank supported the expected advantages of the Patient-Reported Outcomes Measurement Information System (PROMIS). J of Clin Epidem. 2008 61 (1): 17-33.
Bruce B, Fries JF, Murtagh KN. Health status disparities in ethnic minority patients with rheumatoid arthritis: a cross-sectional study. J Rheumatol. 2007 Jul;34(7):1475-9.
Cella D, Yount, S, Rothrock N, Gershon, R, Cook K, Reeve B, Ader D, Fries JF, Bruce B, Rose R on behalf of the PROMIS Cooperative Group. The Patient-Reported Outcomes Measurement Information System (PROMIS): Progress of an NIH Roadmap Cooperative Group During its First Two Years. Med Care. 2007 May;45(5 Suppl 1):S3-S11.
Chakravarty EF, Bjorner JB, Fries JF. Improving patient reported outcomes using item response theory and computerized adaptive testing. J Rheumatol. 2007 Jun;34(6):1426-31.
Krishnan E, Fries JF, Kwoh CK. Primary knee and hip arthroplasty among nonagenarians and centenarians in the United States. Arthritis Rheum 2007 57(6):1038-1042.
Wasko MC, Hubert HB, Lingala VB, Elliott JR, Luggen ME, Fries JF, Ward MM. Hydroxychloroquine and risk of diabetes in patients with reheumatoid arthritis. JAMA 2007 Jul;298(2):187-193.
Berk DR, Hubert HB, Fries JF. Associations of changes in exercise level with subsequent disability among seniors: a 16-year longitudinal study. J Gerontol A Biol Sci Med Sci 2006;61(1):97-102.
Chakravarty EF, Fries JF. Science as experiment; science as observation. Nat Clin Pract Rheumatol 2006;2(6):286-7.
Chakravarty EF, Hubert HB, Lingala B, Fries JF. Reduced disability and mortality among older runners: A 21-year longitudinal study. Arthritis Rheum 2006;54(9 Suppl);S338.
Fries JF The promise of the future, updated: better outcome tools, greater relevance, more efficient study, lower research costs. Future Rheumatol. 2006 1(4), 415-421.
Fries JF, Bruce B, Ambrosini D, Lingala B, Ware JE. Better assessment of disability outcomes: Item improvement is neglected but essential. Arthritis Rheum 2006;54(9 Suppl);S534.
Fries JF, Bruce B, Bjorner J, Rose M “More relevant, precise, and efficient items for assessment of physical function and disability: moving beyond the classic instruments. Ann Rheum Dis. 2006 Nov;65 Suppl 3:iii16-iii21.
Hubert HB, Lingala B, Fries JF. Lifestyle risk factors predict disability and death in an aging cohort. Arthritis Rheum 2006;54(9 Suppl);S534.
Ortendahl M, Fries JF. A low tension between individual and societal time aspects in health improved outcomes. J Clin Epidemiol 2006;59(11):1222-7.
Wasko MC, Luggen M, Sibley J, Lingala B, Fries JF, Hubert HB. Hydroxychloroquine reduces diabetes risk in RA. Arthritis Rheum 2006;54(9 Suppl);S785.
Bruce B, Fries JF. The Arthritis, Rheumatism and Aging Medical Information System (ARAMIS): still young at 30 years. Clin Exp Rheumatol 2005;23(5 Suppl 39):S163-7.
Bruce B, Fries JF. The Health Assessment Questionnaire (HAQ). Clin Exp Rheumatol 2005;23(5 Suppl 39):S14-8.
Bruce B, Fries JF, Lubeck DP. Aerobic exercise and its impact on musculoskeletal pain in older adults: a 14 year prospective, longitudinal study. Arthritis Res Ther 2005;7(6):R1263-70.
Fries JF. Frailty, heart disease, and stroke: the Compression of Morbidity paradigm. Am J Prev Med 2005;29(5 Suppl 1):164-8.
Fries JF. The compression of morbidity. 1983. Milbank Q 2005;83(4):801-23.
Fries JF, Bruce B, Cella D. The promise of PROMIS: using item response theory to improve assessment of patient-reported outcomes. Clin Exp Rheumatol 2005;23(5 Suppl 39):S53-7.
Hueber W, Kidd BA, Tomooka BH, Lee BJ, Bruce B, Fries JF, et al. Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum 2005;52(9):2645-55.
Krishnan E, Fries JF. Rheumatoid arthritis: radiographic progression is getting milder. J Rheumatol 2005;32(1):195; author reply 195.
Lassere MN, Johnson KR, Woodworth TG, Furst DE, Fries JF, Kirwan JR, et al. Challenges and progress in adverse event ascertainment and reporting in clinical trials. J Rheumatol 2005;32(10):2030-2.
Ortendahl M, Fries JF. Framing health messages based on anomalies in time preference. Med Sci Monit 2005;11(8):RA253-6.
Tugwell P, Judd MG, Fries JF, Singh G, Wells GA. Powering our way to the elusive side effect: a composite outcome 'basket' of predefined designated endpoints in each organ system should be included in all controlled trials. J Clin Epidemiol 2005;58(8):785-90.
Bruce B, Fries, JF. Longitudinal Comparison of the Health Assessment Questionnaire (HAQ) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Arthritis Care Research 2004;51(5):730-737.
Fries JF. Robine and Michel's "Looking Forward to a General Theory on Population Aging": Commentary. J Gerontol A Biol Sci Med Sci 2004;59(6):M603-5.
Fries JF. New instruments for assessing disability: not quite ready for prime time. Arthritis Rheum 2004;50(10):3064-7.
Fries JF, Bruce B. Drs. Fries and Bruce reply:Serious Gastrointestinal Events from Low Dose Analgesic Use. J Rheumatol 2004;31(5):1010.
Fries JF, Krishnan E. Equipoise, design bias, and randomized controlled trials: the elusive ethics of new drug development. Arthritis Res Ther 2004;6(3):R250-5.
Fries JF, Murtagh KN, Bennett M, Zatarain E, Lingala B, Bruce B. The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis. Arthritis Rheum 2004;50(8):2433-40.
Krishnan E, Fries JF. Measuring effectiveness of drugs in observational databanks: promises and perils. Arthritis Res Ther 2004;6(2):41-4.
Krishnan E, Murtagh K, Bruce B, Cline D, Singh G, Fries JF. Attrition bias in rheumatoid arthritis databanks: a case study of 6346 patients in 11 databanks and 65,649 administrations of the health assessment questionnaire. J Rheumatol 2004;31(7):1320-6.
Krishnan E, Tugwell P, Fries JF. Percentile benchmarks in patients with rheumatoid arthritis: Health Assessment Questionnaire as a quality indicator (QI). Arthritis Res Ther 2004;6(6):R505-13.
Lorig KR, Ritter PL, Laurent DD, Fries JF. Long-term randomized controlled trials of tailored-print and small-group arthritis self-management interventions. Med Care 2004;42(4):346-54.
Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: A Review of Its History, Issues, Progress, and Documentation. J Rheumatol 2003;30(1):167-178.
Bruce Bonnie, Fries James F. The Stanford Health Assessment Questionnaire: Dimensions and Practical Applications. Health and Quality of Life Outcomes 2003, I:20.
Fries JF. Aging, natural death, and the compression of morbidity. 1980. Bull World Health Organ. 2002;80(3):245-50.
Fries, JF. Reducing Disability in Older Age. JAMA:2002;288(24):3164-3166
Fries JF. Successful aging – an emerging paradigm of gerontology. Clin Geriatr Med, 2002;18:1-12.
Fries JF, Wolfe F, Apple R, Erlich H, Bugawan T, Holmes T, Bruce B. HLA-DRB1 Genotype Associations in 793 Caucasian Inception Cohort Patients with Rheumatoid Arthritis (RA): Frequency, Severity, and Treatment Bias. Arthritis Rheum, 2002;46(9):2320-2329.

Albert D, Aksentijevich S, Hurs S, Fries J, Wolfe F. Modeling Therapeutic Strategies in Rheumatoid Arthritis: Use of Decision Analysis and Markov Models. J Rheum. 2000;27(3):644-652.
Fries J. Current Treatment Paradigms in Rheumatoid Arthritis. Rheumatology. 2000;39(Suppl 1):30-35.
Lubeck D, Hubert H, Fries J. Properties of the Health Assessment Questionnaire, CES-D and Modified MOS Scales in a community population of seniors. Quality of Life Research. 2000;9(3):327.
Ortendahl M, Schettler JD, Fries JF. Factors influencing length of time taking methotrexate in rheumatoid arthritis. J Rheumatol. 2000;27(5):1139-47.
Albert D, Hurst S, Kallan M, Wolfe F, Fries J. The results of DMARD treatment on overall outcome of rheumatoid arthritis in a large cohort: sequence effects. Arthritis Rhem. 1999;42:S216.
Albert D, Hurst S, Kallan M, Wolfe F, Fries J. The results of DMARD treatment on overall outcome of rheumatoid arthritis in a large cohort: Estimates of relative drug effectiveness. Arthritis Rheum. 1999;42:S71.
Fries J, Schettler J, Ramey D. Methotrexate and mortality in theumatoid arthritis (RA): Simpson paradox and other methodological problems. Arthritis Rheum. 1999;42:S135.
Fries JF. Safety, cost and effectiveness issues with disease modifying anti- rheumatic drugs in rheumatoid arthritis. Ann Rheum Dis. 1999;58 Suppl 1:I86-9.
Hubert H, Bloch D, Oehlert J, Fries J. Life-style habits and compression of morbidity. Arthritis Rheum. 1999;42:S223.
Manek N, Chong M, Fries J, Lane N. Longitudinal progression of radiographic hand osteoarthritis. Arthritis Rheum. 1999;42:S297.
Wang B, Fries J. Area under the curve (AUC) as a model of cummulative disability in rheumatoid arthritis. Arthritis Rheum. 1999;42:S219.
Wang B, Wolfe F, Fries J. Reduction in cummulative disability with increasing exposure to methotrexate in rheumatoid arthritis. Arthritis Rheum. 1999;42:S380.
Fries J. Quality-of-life considerations with respect to arthritis and nonsteroidal anti-inflammatory drugs. American Journal of Medicine. 1998;104:14S-20S; discussion 21S-2.
Fries J. The Epidemiology of NSAID Gastropathy: The ARAMIS Experience. Jnl of Clinical Rheumatology. 1998;4:S11-S16.
Fries J, Koop C, Sokolov J, Beadle C, Wright D. Beyond health promotion: reducing need and demand for medical care. Health Affairs. 1998;17:70-84.
Fries JF. Reducing cumulative lifetime disability: the compression of morbidity. Br J Sports Med. 1998;32(3):193.
Fries JF, McShane D. Reducing need and demand for medical services in high-risk persons. A health education approach. West J Med. 1998;169(4):201-7.
Lane NE, Oehlert JW, Bloch DA, Fries JF. The relationship of running to osteoarthritis of the knee and hip and bone mineral density of the lumbar spine: a 9 year longitudinal study. J Rheumatol. 1998;25(2):334-41.
Vita AJ, Terry RB, Hubert HB, Fries JF. Aging, health risks, and cumulative disability. N Engl J Med. 1998;338(15):1035-41.
Ward MM, Fries JF. Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981-1996. J Rheumatol. 1998;25(3):408-16.
Fries J. Can preventive gerontology be on the way? [editorial]. Amer Jnl of Public Health. 1997;87:1591-3.
Fries J, Williams C, Singh G, Ramey D. Response to therapy in rheumatoid arthritis is influenced by immediately prior therapy. Jnl of Rheumatology. 1997;24:838-44.
Fries JF. Reducing the need and demand for medical care: implications for quality management and outcome improvement. Qual Manag Health Care. 1997;6(1):34-44.
Fries JF, Carey C, McShane DJ. Patient education in arthritis: randomized controlled trial of a mail- delivered program. J Rheumatol. 1997;24(7):1378-83.
Fries JF, Ramey DR. "Arthritis specific" global health analog scales assess "generic" health related quality-of-life in patients with rheumatoid arthritis. J Rheumatol. 1997;24(9):1697-702.
Fries J. Non-steroidal anti-inflammatory drug safety: a view from the ARAMIS databank. Current Opinions in Rheumatology. 1996;8 (suppl 1):S3-S7.
Fries J. Toward an understanding of NSAID-related adverse events: the continuation of longitudinal data. The Scandinavian Jnl of Rheumatology. 1996;102:3-8.
Fries JF. Effectiveness and toxicity considerations in outcome directed therapy in rheumatoid arthritis. J Rheumatol Suppl. 1996;44:102-6.
Fries JF. Selective cyclooxygenase inhibition: promise for future NSAID therapy? Scand J Rheumatol Suppl. 1996;102(1):1.
Fries JF. Physical activity, the compression of morbidity, and the health of the elderly. J R Soc Med. 1996;89(2):64-8.
Fries JF. Prevention of osteoporotic fractures: possibilities, the role of exercise, and limitations. Scand J Rheumatol Suppl. 1996;103:6-10.
Fries JF, Williams CA, Morfeld D, Singh G, Sibley J. Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies. Arthritis Rheum. 1996;39(4):616-22.
Gironimi G, Clarke AE, Hamilton VH, et al. Why health care costs more in the US: comparing health care expenditures between systemic lupus erythematosus patients in Stanford and Montreal. Arthritis Rheum. 1996;39(6):979-87.
Henry D, Lim LL, Garcia Rodriguez LA, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta- analysis. Bmj. 1996;312(7046):1563-6.
Sampalis JS, Medsger TA, Fries JF, et al. Risk factors for adult Still's disease. J Rheumatol. 1996;23(12):2049-54.
Singh G, Ramey DR, Morfeld D, Shi H, Hatoum HT, Fries JF. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. Arch Intern Med. 1996;156(14):1530-6.
Singh G, Terry R, Ramey D, Wolfe F, Fries J. Long-term medical costs and outcomes are significantly asociated with early changes in disability in rheumatoid arthritis. Arthritis Rheum. 1996;39:S318.
Fries J. The toxicity of anti-rheumatic drugs: Problems and solutions. Proc R Coll Physicians Edinb. 1995;25:398-405.
Fries J. A new treatment approach: DMARD-based sequential therapy. Hosp Pract. 1995:23-30.
Fries JF. ARAMIS and toxicity measurement. (Arthritis Rheumatism and Aging Medical Information System). J Rheumatol. 1995;22(5):995-7.
Fries JF, Singh G. Glucocorticoids and joint destruction in rheumatoid arthritis. N Engl J Med. 1995;333(23):1569; discussion 1570.
Fries JF, Harrington H, Edwards R, Kent LA, Richardson N. Randomized controlled trial of cost reductions from a health education program: the California Public Employees' Retirement System (PERS) study. Am J Health Promot. 1994;8(3):216-23.
Fries JF, Hochberg MC, Medsger TA, Hunder GG, Bombardier C. Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1994;37(4):454-62.
Fries JF, Singh G, Morfeld D, Hubert HB, Lane NE, Brown BW. Running and the development of disability with age. Ann Intern Med. 1994;121(7):502-9.
Hubert H, Fries J. Predictors of physical disability after age 50: six-year longitudinal study in a runners club and university population. Ann Epidemiol. 1994;4:285-294.
Leigh JP, Fries JF. Correlations between education and arthritis in the 1971-1975 NHANES I. Soc Sci Med. 1994;38(4):575-83.
Leigh JP, Fries JF. Education, gender, and the compression of morbidity. Int J Aging Hum Dev. 1994;39(3):233-46.
Leigh JP, Fries JF. Arthritis and mortality in the epidemiological follow-up to the National Health and Nutrition Examination Survey I. Bull N Y Acad Med. 1994;71(1):69-86.
Montgomery E, Lieberman A, Singh G, Fries J. Patient education and health promotion can be effective in Parkinson's Disease: A randomized controlled trial. Amer Jnl of Medicine. 1994;97:429-435.
Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1994;37(12):1761-9.
Singh G, Ramey DR, Morfeld D, Fries JF. Comparative toxicity of non-steroidal anti-inflammatory agents. Pharmacol Ther. 1994;62(1-2):175-91.
Wolfe F, Mitchell DM, Sibley JT, et al. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994;37(4):481-94.
Clarke AE, Esdaile JM, Bloch DA, Lacaille D, Danoff DS, Fries JF. A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. Arthritis Rheum. 1993;36(11):1548-59.
Edworthy SM, Bloch DA, Brant RF, Fries JF. Detecting treatment effects in patients with rheumatoid arthritis: the advantage of longitudinal data. J Rheumatol. 1993;20(1):40-4.
Fries J. Compression of morbidity 1993: life span, disability, and health care costs. Facts and Research in Gerontology. 1993;7:183-190.
Fries J, Singh G, Morfeld D, Hubert H, Lane N, Brown B. Running activity and the development of disability with age: 8-year longitudinal study. . 1993.
Fries JF, Bloch DA, Harrington H, Richardson N, Beck R. Two-year results of a randomized controlled trial of a health promotion program in a retiree population: the Bank of America Study. Am J Med. 1993;94(5):455-62.
Fries JF, Koop CE, Beadle CE, et al. Reducing health care costs by reducing the need and demand for medical services. The Health Project Consortium. N Engl J Med. 1993;329(5):321-5.
Fries JF, Ramey DR. Platonic outcomes. J Rheumatol. 1993;20(3):415-7.
Fries JF, Ramey DR, Singh G, Morfeld D, Bloch DA, Raynauld JP. A reevaluation of aspirin therapy in rheumatoid arthritis. Arch Intern Med. 1993;153(21):2465-71.
Fries JF, Williams CA, Ramey D, Bloch DA. The relative toxicity of disease-modifying antirheumatic drugs. Arthritis Rheum. 1993;36(3):297-306.
Hubert HB, Bloch DA, Fries JF. Risk factors for physical disability in an aging cohort: the NHANES I Epidemiologic Followup Study. J Rheumatol. 1993;20(3):480-8.
Lane NE, Michel B, Bjorkengren A, et al. The risk of osteoarthritis with running and aging: a 5-year longitudinal study. J Rheumatol. 1993;20(3):461-8.
Leigh J, Fries J. Associations among health habits, age, gender, and education in a sample of retirees. Int'l Aging Human Dev. 1993;36:139-152.
Leigh JP, Fries JF. Tobit, fixed effects, and cohort analyses of the relationship between severity and duration of rheumatoid arthritis. Soc Sci Med. 1993;36(11):1495-502.
Leigh JP, Ward MM, Fries JF. Reducing attrition bias with an instrumental variable in a regression model: results from a panel of rheumatoid arthritis patients. Stat Med. 1993;12(11):1005-18.
Michel BA, Bloch DA, Wolfe F, Fries JF. Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheumatol. 1993;20(10):1666-9.
Raynauld JP, Bloch DA, Fries JF. Seasonal variation in the onset of Wegener's granulomatosis, polyarteritis nodosa and giant cell arteritis. J Rheumatol. 1993;20(9):1524-6.
Raynauld JP, Lee YS, Kornfeld P, Fries JF. Unilateral ptosis as an initial manifestation of D-penicillamine induced myasthenia gravis. J Rheumatol. 1993;20(9):1592-3.
Ward MM, Leigh JP, Fries JF. Progression of functional disability in patients with rheumatoid arthritis. Associations with rheumatology subspecialty care. Arch Intern Med. 1993;153(19):2229-37.
Fries J. The chronic disease data bank model: a conceptual framework for the computer-based medical record. Comp and Biomedical Research. 1992;25:586-601.
Fries J. By the International Study Group for Behcet's Disease: Evaluation of diagnostic. The British Jnl of Rheumatology. 1992;31:299-308.
Fries JF. Strategies for reduction of morbidity. Am J Clin Nutr. 1992;55(6 Suppl):1257S-1262S.
Fries JF, Fries ST, Parcell CL, Harrington H. Health risk changes with a low-cost individualized health promotion program: effects at up to 30 months. Am J Health Promot. 1992;6(5):364-71.
Fries JF, Seibold JR, Medsger TA. Photopheresis for scleroderma? No! J Rheumatol. 1992;19(7):1011-3.
Fries JF, Williams CA, Morfeld D. Improvement in intergenerational health. Am J Public Health. 1992;82(1):109-12.
Leigh JP, Fries JF. Disability in occupations in a national sample. Am J Public Health. 1992;82(11):1517-24.
Leigh JP, Fries JF. Health habits, health care use and costs in a sample of retirees. Inquiry. 1992;29(1):44-54.
Leigh JP, Fries JF. Predictors of disability in a longitudinal sample of patients with rheumatoid arthritis. Ann Rheum Dis. 1992;51(5):581-7.
Leigh JP, Fries JF, Hubert HB. Gender and race differences in the correlation between body mass and education in the 1971-1975 NHANES I. J Epidemiol Community Health. 1992;46(3):191-6.
Leigh JP, Fries JF, Parikh N. Severity of disability and duration of disease in rheumatoid arthritis. J Rheumatol. 1992;19(12):1906-11.
Leigh JP, Richardson N, Beck R, et al. Randomized controlled study of a retiree health promotion program. The Bank of American Study. Arch Intern Med. 1992;152(6):1201-6.
Michel BA, Bloch DA, Fries JF. Physical activity and fractures over the age of fifty years. Int Orthop. 1992;16(1):87-91.
Michel BA, Fries JF, Bloch DA, Lane NE, Jones HH. Osteophytosis of the knee: association with changes in weight-bearing exercise. Clin Rheumatol. 1992;11(2):235-8.
Michel BA, Lane NE, Bjorkengren A, Bloch DA, Fries JF. Impact of running on lumbar bone density: a 5-year longitudinal study. J Rheumatol. 1992;19(11):1759-63.
Ramey DR, Raynauld JP, Fries JF. The health assessment questionnaire 1992: status and review. Arthritis Care Res. 1992;5(3):119-29.
Fries J. NSAID gastropathy: the second most deadly rheumatic disease? Jnl of Rheumatology. 1991;18:6-10.
Fries J, Spitz P, Bloch D, Williams C. Factors in the duration and discontinuation of treatment with nonsteroidal and anti-inflammatory medications. Excertpa Medica. 1991;3:51-62.
Fries JF. The hierarchy of quality-of-life assessment, the Health Assessment Questionnaire (HAQ), and issues mandating development of a toxicity index. Control Clin Trials. 1991;12(4 Suppl):106S-117S.
Fries JF, Williams CA, Bloch DA. The relative toxicity of nonsteroidal antiinflammatory drugs. Arthritis Rheum. 1991;34(11):1353-60.
Fries JF, Williams CA, Bloch DA, Michel BA. Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med. 1991;91(3):213-22.
Leigh JP, Fries JF. Mortality predictors among 263 patients with rheumatoid arthritis. J Rheumatol. 1991;18(9):1307-12.
Leigh JP, Fries JF. Occupation, income, and education as independent covariates of arthritis in four national probability samples. Arthritis Rheum. 1991;34(8):984-95.
Leigh JP, Fries JF. Education level and rheumatoid arthritis: evidence from five data centers. J Rheumatol. 1991;18(1):24-34.
Michel B, Lane N, Bloch D, Hones H, Fries J. Effect of changes in weight-bearing exercise on lumbar bone mass after age fifty. Annals of Internal Medicine. 1991;23:397-401.
Michel BA, Bloch DA, Fries JF. Predictors of fractures in early rheumatoid arthritis. J Rheumatol. 1991;18(6):804-8.
Seleznick MJ, Fries JF. Variables associated with decreased survival in systemic lupus erythematosus. Semin Arthritis Rheum. 1991;21(2):73-80.
Singh G, Fries JF, Williams CA, Zatarain E, Spitz P, Bloch DA. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis. J Rheumatol. 1991;18(2):188-94.
Bloch DA, Michel BA, Hunder GG, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. Arthritis Rheum. 1990;33(8):1068-73.
Calabrese LH, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum. 1990;33(8):1108-13.
Fries J, Singh G, Lenert L, Furst D. Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate. Arthritis Rheum. 1990;33:1611-1619.
Fries J, Spitz P, Williams C, Singh G, Bloch D, Hubert H. A toxicity index for comparison of side effects among different drugs. Arthritis Rheum. 1990;33:121-130.
Fries JF. Reevaluating the therapeutic approach to rheumatoid arthritis: the "sawtooth" strategy. J Rheumatol Suppl. 1990;22:12-5.
Fries JF. Safety issues related to DMARD therapy. J Rheumatol Suppl. 1990;25:14-7.
Fries JF, Hunder GG, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum. 1990;33(8):1135-6.
Hunder GG, Arend WP, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum. 1990;33(8):1065-7.
Lane NE, Bloch DA, Hubert HB, Jones H, Simpson U, Fries JF. Running, osteoarthritis, and bone density: initial 2-year longitudinal study. Am J Med. 1990;88(5):452-9.
Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990;33(8):1101-7.
Michel BA, Lane NE, Jones HH, Fries JF, Bloch DA. Plain radiographs can be useful in estimating lumbar bone density. J Rheumatol. 1990;17(4):528-31.
Fries J. Living Well. Reading, Massachusetts: Addison-Wesley Publishing Company; 1989, 1993, 1999.
Edworthy SM, Bloch DA, McShane DJ, Segal MR, Fries JF. A "state model" of renal function in systemic lupus erythematosus: its value in the prediction of outcome in 292 patients. J Rheumatol. 1989;16(1):29-35.
Fries J, Miller S, Spitz P, Williams C, Hubert H, Bloch D. Toward an epidemiology of gastropathy associated with nonsteroidal anti-inflammatory drugs. Gastroenterology. 1989;96:647-655.
Fries JF. Advances in management of rheumatic disease. 1965 to 1985. Arch Intern Med. 1989;149(5):1002-11.
Fries JF. The compression of morbidity: near or far? Milbank Q. 1989;67(2):208-32.
Fries JF, Green LW, Levine S. Health promotion and the compression of morbidity. Lancet. 1989;1(8636):481-3.
Fries JF, Singh G, Bloch DA, Calin A. The natural history of ankylosing spondylitis: is the disease really changing? J Rheumatol. 1989;16(7):860-3.
Lane NE, Bloch DA, Jones HH, Simpson U, Fries JF. Osteoarthritis in the hand: a comparison of handedness and hand use. J Rheumatol. 1989;16(5):637-42.
Lyon MG, Bloch DA, Hollak B, Fries JF. Predisposing factors in polymyositis-dermatomyositis: results of a nationwide survey. J Rheumatol. 1989;16(9):1218-24.
Michel B, Bloch D, Fries J. Weight-bearing exercise, overexercise, and limbar bone density over age fifty. Arch Intern Med. 1989;149:2325-2329.
Singh G, Fries JF, Spitz P, Williams CA. Toxic effects of azathioprine in rheumatoid arthritis. A national post- marketing perspective. Arthritis Rheum. 1989;32(7):837-43.
Wysenbeek AJ, Block DA, Fries JF. Prevalence and expression of photosensitivity in systemic lupus erythematosus. Ann Rheum Dis. 1989;48(6):461-3.
Albridge KM, Standish J, Fries JF. Hierarchical time-oriented approaches to missing data inference. Comput Biomed Res. 1988;21(4):349-66.
Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315-24.
Fries J. Milestones in Rheumatologic Patient Care: 1965-1985. Humacao, Puerto Rico: Syntex Puerto Rico, Inc.; 1988.
Fries JF. Aging, illness, and health policy: implications of the compression of morbidity. Perspect Biol Med. 1988;31(3):407-28.
Fries JF. Postmarketing drug surveillance: are our priorities right? J Rheumatol. 1988;15(3):389-90.
Fries JF, Bloch DA, Segal MR, Spitz PW, Williams C, Lane NE. Postmarketing surveillance in rheumatology: analysis of purpura and upper abdominal pain. J Rheumatol. 1988;15(2):348-55.
Lane NE, Fries JF. Relationship of running to osteoarthritis and bone density. Compr Ther. 1988;14(2):7-15.
McShane D, Fries J. The chronic disease data bank - the ARAMIS experience. . IEEE.; 1988:672-679.
Wolfe F, Kleinheksel SM, Cathey MA, Hawley DJ, Spitz PW, Fries JF. The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis. J Rheumatol. 1988;15(10):1480-8.
Altman RD, Fries JF, Bloch DA, et al. Radiographic assessment of progression in osteoarthritis. Arthritis Rheum. 1987;30(11):1214-25.
Fries J. Reduction of the national morbidity. Gerontological Perspectives. 1987;1:54-65.
Lane NE, Bloch DA, Wood PD, Fries JF. Aging, long-distance running, and the development of musculoskeletal disability. A controlled study. Am J Med. 1987;82(4):772-80.
Sherrer Y, Bloch D, Strober S, Fries J. Comparative toxicity of total lymphoid irradiation and immunosuppressive drug treated patients with intractable rheumatoid arthritis. J Rheumatol. 1987;14(1):46-51.
Sherrer YS, Bloch DA, Mitchell DM, Roth SH, Wolfe F, Fries JF. Disability in rheumatoid arthritis: comparison of prognostic factors across three populations. J Rheumatol. 1987;14(4):705-9.
Fries J. Measuring the quality of life: the new science of patient-outcome assessment. Mediguide to Inflammatory Diseases. 1986;4:1-6.
Fries JF. The future of disease and treatment. Changing health conditions, changing behaviors, and new medical technology. J Prof Nurs. 1986;2(1):10-9.
Fries JF, Bloch DA, Sharp JT, et al. Assessment of radiologic progression in rheumatoid arthritis. A randomized, controlled trial. Arthritis Rheum. 1986;29(1):1-9.
Fries JF, McShane DJ. ARAMIS (the American Rheumatism Association Medical Information System). A prototypical national chronic-disease data bank. West J Med. 1986;145(6):798-804.
Fries JF, Spitz PW, Mitchell DM, Roth SH, Wolfe F, Bloch DA. Impact of specific therapy upon rheumatoid arthritis. Arthritis Rheum. 1986;29(5):620-7.
Lane NE, Bloch DA, Jones HH, Marshall WH, Wood PD, Fries JF. Long-distance running, bone density, and osteoarthritis. JAMA. 1986;255(9):1147-51.
Lubeck DP, Spitz PW, Fries JF, Wolfe F, Mitchell DM, Roth SH. A multicenter study of annual health service utilization and costs in rheumatoid arthritis. Arthritis Rheum. 1986;29(4):488-93.
Mitchell D, Spitz P, Young D, Bloch D, McShane D, Fries J. Mortality in rheumatoid arthritis. . 1986.
Mitchell DM, Spitz PW, Young DY, Bloch DA, McShane DJ, Fries JF. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum. 1986;29(6):706-14.
Sherrer YS, Bloch DA, Mitchell DM, Young DY, Fries JF. The development of disability in rheumatoid arthritis. Arthritis Rheum. 1986;29(4):494-500.
Wolfe F, Kleinheksel SM, Spitz PW, et al. A multicenter study of hospitalization in rheumatoid arthritis: effect of health care system, severity, and regional difference. J Rheumatol. 1986;13(2):277-84.
Fries J. The ARAMIS (American Rheumatism Association Medical Information System) post-marketing surveillance program. Drug Information Jnl. 1985;19:257-262.
Fries JF. Epidemiology of cancer in rheumatoid arthritis: methodologic pitfalls. Am J Med. 1985;78(1A):12-4.
Fries JF, Bloch D, Spitz P, Mitchell DM. Cancer in rheumatoid arthritis: a prospective long-term study of mortality. Am J Med. 1985;78(1A):56-9.
Brown JH, Kazis LE, Spitz PW, Gertman P, Fries JF, Meenan RF. The dimensions of health outcomes: a cross-validated examination of health status measurement. Am J Public Health. 1984;74(2):159-61.
Fries J. The compression of morbidity: miscellaneous comments about a theme. The Gerontologist. 1984;24:355-359.
Fries J. ARAMIS: A National Arthritis Data Resource. . Current Topic in Rheumatology: Epidemiology of the Rheumatic Disease. New York, NY: Gower Medical Publications; 1984:355-358.
Fries JF. The chronic disease data bank: first principles to future directions. J Med Philos. 1984;9(2):161-80.
Fries JF. Disease criteria for systemic lupus erythematosus. Arch Intern Med. 1984;144(2):252-3.
Fries JF, Wasner C, Brown J, Feigenbaum P. A controlled trial of antihypertensive therapy in systemic sclerosis (scleroderma). Ann Rheum Dis. 1984;43(3):407-10.
Lubeck D, Spitz P, Fries J. The Health Assessment Questionnaire (HAQ): assessment of personal economic costs. Arthritis Rheum. 1984:S24.
Sherrer Y, Young D, Fries J, Wolfe F, Mitchell D. Comparability if prediction of rheumatoid disability outcome across populations. . 1984.
Coles LS, Fries JF, Kraines RG, Roth SH. From experiment to experience: side effects of nonsteroidal anti- inflammatory drugs. Am J Med. 1983;74(5):820-8.
Fries J. Toward an understanding of patient outcome measurement. Arthritis Rheum. 1983;26:697-704.
Fries J. Clinical criteria for diagnosing the spondyloarthropathies. Jnl of Musculoskeletal Medicine. 1983;1:57-61.
Fries J. Receiver operating characteristic curves of the revised criteria for the classification of SLE. Arthritis Rheum. 1983;26:1055.
Fries JF. The assessment of disability: from first to future principles. Br J Rheumatol. 1983;22(3 Suppl):48-58.
Fries JF. The compression of morbidity. Milbank Mem Fund Q Health Soc. 1983;61(3):397-419.
Sherrer Y, Mitchell D, Fries J. Predictors of disability in rheumatoid arthritis (RA). Arthritis Rheum. 1983;26:S54.
Feigenbaum PA, Medsger TA, Kraines RG, Fries JF. The variability of immunologic laboratory tests. J Rheumatol. 1982;9(3):408-14.
Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol. 1982;9(5):789-93.
Ginzler EM, Diamond HS, Weiner M, et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum. 1982;25(6):601-11.
Mitchell DM, Fries JF. An analysis of the American Rheumatism Association criteria for rheumatoid arthritis. Arthritis Rheum. 1982;25(5):481-7.
Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271-7.
Pantell R, Fries J, Vickery D. Taking Care of Your Child. Reading, Massachusetts: Addison-Wesley; 1981, 1986, 1990, 1999.
Lorig K, Fries J. The Arthritis Helpbook. Menlo Park, CA: Addison-Wesley; 1981 , 1986, 1990, 1995, 1999.
Fries J, Crapo L. Vitality and Aging. San Francisco, CA: WH Freeman Company; 1981.
Wasner C, Britton MC, Kraines RG, Kaye RL, Bobrove AM, Fries JF. Nonsteroidal anti-inflammatory agents in rheumatoid arthritis and ankylosing spondylitis. JAMA. 1981;246(19):2168-72.
Fries J. Arthritis: A Comprehensive Guide. Reading, Massachusetts: Addison-Wesley; 1980, 1986, 1990, 1994, 1999.
Brown J, Spitz P, Fries J. Non-traditional treatments in rheumatoid arthritis. Arthritis Rheum. 1980;23:657.
Coles LS, Brown BW, Engelhard C, Halpern J, Fries JF. Determining the most valuable clinical variables: a stepwise multiple logistic regression program. Methods Inf Med. 1980;19(1):42-9.
Fries J, Ehrlich G. Prognosis: A Textbook of Medical Prognosis. Bowie, Maryland: The Charles Press Publishers; 1980.
Fries JF. Aging, natural death, and the compression of morbidity. N Engl J Med. 1980;303(3):130-5.
Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23(2):137-45.
Wasner CK, Fries JF. Treatment decisions in systemic lupus erythematosus. Arthritis Rheum. 1980;23(3):283-6.
Dannenberg AL, Shapiro AR, Fries JF. Enhancement of clinical predictive ability by computer consultation. Methods Inf Med. 1979;18(1):10-4.
Feigenson JS, Fries JF, Kunitz S, McShane D, Greenberg SD. Time-oriented functional profile: practical applications in a stroke data-base model. Arch Phys Med Rehabil. 1979;60(11):512-6.
Fries JF. The microvascular pathogenesis of scleroderma: an hypothesis. Ann Intern Med. 1979;91(5):788-9.
Fries JF. The approach to the rheumatic disease patient. Compr Ther. 1979;5(8):8-15.
McShane D, Harlow A, Kraines R, Fries J. TOD: a software system for the ARAMIS data bank. Computer. 1979;12:34-40.
Calin A, Fries J. Ankylosing Spondylitis: Discussion in Patient Management. Garden City, New Jersey: Medical Examination Publishing Co, Inc; 1978.
Fries JF. Education for outcome. J Rheumatol. 1978;5(1):1-2.
Fries JF, Porta J, Liang MH. Marginal benefit of renal biopsy in systemic lupus erythematosus. Arch Intern Med. 1978;138(9):1386-9.
Liang M, Schurman DJ, Fries J. A patient-administered questionnaire for arthritis assessment. Clin Orthop. 1978(131):123-9.
Liang MH, Fries JF. Containing costs in chronic disease: monitoring strategies in the gold therapy of rheumatoid arthritis. J Rheumatol. 1978;5(3):241-4.
Liang MH, Fries JF. Asymptomatic hyperuricemia: the case for conservative management. Ann Intern Med. 1978;88(5):666-70.
McShane DJ, Porta J, Fries JF. Comparison of therapy in severe systemic lupus erythematosus employing stratification techniques. J Rheumatol. 1978;5(1):51-8.
Wasner C, Cooke CR, Fries JF. Successful medical treatment of scleroderma renal crisis. N Engl J Med. 1978;299(16):873-5.
Calin A, Fries JF, Schurman D, Payne R. The close correlation between symptoms and disease expression in HLA B27 positive individuals. J Rheumatol. 1977;4(3):277-81.
Calin A, Porta J, Fries JF, Schurman DJ. Clinical history as a screening test for ankylosing spondylitis. JAMA. 1977;237(24):2613-4.
Fries JF. The clinical aspects of systemic lupus erythematosus. Med Clin North Am. 1977;61(2):229-40.
Fries JF. Editorial: A data bank for the clinician? N Engl J Med. 1976;294(25):1400-2.
Fries JF, Britton MC. Some problems in the interpretation of clinical trials: longterm parallel study of fenoprofen in rheumatoid arthritis. J Rheumatol. 1976;2:61-5.
Fries JF, Mitchell DM. Joint pain or arthritis. JAMA. 1976;235(2):199-204.
Vickery D, Fries J. Take Care of Yourself: A Consumer's Guide to Medical Care. Reading, Massachusetts: Addison-Wesley; 1975, 1980, 1986, 1990, 1993, 1995, 1998.
Fries J, Holman H. Systemic Lupus Erythmatosus. Philadelphia: WB Saunders; 1975.
Weyl S, Fries J, Wiederhold G, Germano F. A modular self-describing clinical databank system. Comput Biomed Res. 1975;8(3):279-93.
Wiederhold G, Fries J, Weyl S. Structured organization of clinical databases. . AFIPS Conference Proceedings.; 1975:479-485.
Fries JF. Alternatives in medical record formats. Med Care. 1974;12(10):871-81.
Fries JF, Weyl S, Holman HR. Estimating prognosis in systemic lupus erythematosus. Am J Med. 1974;57(4):561-5.
Fries JF, Sharp GC, McDevitt HO, Holman HR. Cyclophosphamide therapy in systemic lupus erythematosus and polymyositis. Arthritis Rheum. 1973;16(2):154-62.
Fries JF. Time-oriented patient records and a computer databank. JAMA. 1972;222(12):1536-42.